CD8A and hepatocellular carcinoma: These observations suggest that the elevated circulating IL-36 in HCC patients mainly originates from circulating CD4+ T helper and CD8+ cytotoxic T cells, rather than from intrahepatic lymphocytes and/or hepatocytes.